Filtered By:
Condition: Cough
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 318 results found since Jan 2013.
Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning
CONCLUSIONS: The results were noteworthy for infrequent Impaired scores, and significant correlations between cognition and mood/anxiety measures, but not between cognitive performance and premorbid vascular risk factors, psychiatric diagnoses, or COVID-19 disease severity. Results suggest that psychological distress was prominent in PASC and related to objective cognitive performance, but objective cognitive performance was unrelated to cognitive complaints. Other contributing factors may include fatigue/sleep issues. Neurologically based cognitive deficits were not suggested by the results.During the COVID-19 pandemic, r...
Source: The Clinical Neuropsychologist - February 8, 2022 Category: Psychiatry & Psychology Authors: Douglas M Whiteside Michael R Basso Savana M Naini James Porter Erin Holker Eric J Waldron Tanya E Melnik Natalie Niskanen Sarah E Taylor Source Type: research
FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease who have...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Respiratory function in chronic stroke patients: an observational study
Conclusion: Our results showed that chronic stroke patients show significant impairment in pulmonary function, cough effectiveness, and respiratory muscle strength compared to the control group, and as a consequence, a loss of functionality at this level.
Source: European Respiratory Journal - November 25, 2021 Category: Respiratory Medicine Authors: Prados Roman, E., Cabrera Martos, I., Zapata Soria, M., Ortiz Rubio, A., Calvache Mateo, A., Valenza, M. C. Tags: Rehabilitation and chronic care Source Type: research
Post-COVID and the BHRUT one-stop shop MDT approach to managing the longterm sequale of a novel disease process
Conclusions: Patients reported significant physical, functional and psychological issues. These results led to a newly established one-stop face-to-face and virtual MDT clinic with respiratory physician, occupational and physiotherapist and psychologist including digital rehabilitation programmes.
Source: European Respiratory Journal - November 25, 2021 Category: Respiratory Medicine Authors: Kumar, P., Nyberg, S., Jiwan, R., Ainley, A. Tags: Rehabilitation and chronic care Source Type: research
Respiratory Muscle Training Reduces Respiratory Complications and Improves Swallowing Function After Stroke: A Systematic Review and Meta-Analysis
To investigate if respiratory muscle training is capable of reducing the occurrence of respiratory complications and improving dysphagia (swallowing or cough function) after stroke?
Source: Archives of Physical Medicine and Rehabilitation - November 12, 2021 Category: Rehabilitation Authors: Qing Xie, Weisong Zhang, Huijuan Pan, Ya Zong, Jixian Wang Source Type: research
Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Effect of Capsaicin Atomization-Induced Cough on Sputum Excretion in Tracheotomized Patients After Hemorrhagic Stroke: A Randomized Controlled Trial
Conclusions Capsaicin atomization-induced cough can effectively promote sputum excretion of hemorrhagic stroke patients undergoing tracheotomy and has a good safety profile. The Clinical Trial registration number of this study is ChiCTR2000037772 (http://www.chictr.org.cns). Supplemental Material https://doi.org/10.23641/asha.16821352.PMID:34694869 | DOI:10.1044/2021_JSLHR-21-00151
Source: Journal of speech, language, and hearing research : JSLHR - October 25, 2021 Category: Speech-Language Pathology Authors: Chao Wu Yijie Zhang Li Yang Fang Shen Chen Ma Meifen Shen Source Type: research
Corrigendum for Trimble & amp; Patterson (2020), 'Cough reflex testing in acute stroke: A survey of current UK service provision and speech and language therapist perceptions'
Int J Lang Commun Disord. 2021 Oct 18. doi: 10.1111/1460-6984.12677. Online ahead of print.NO ABSTRACTPMID:34662470 | DOI:10.1111/1460-6984.12677
Source: International Journal of Language and Communication Disorders - October 18, 2021 Category: Speech-Language Pathology Source Type: research
